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Abstract
Background: p14ARF is a protein product of the alternative reading frame of the human INK4a
locus. It functions as a tumor suppressor protein. p14ARF suppresses growth through p53-
dependent and p53-independent pathways.
Results: p14ARF protein localizes primarily to the nucleoli. Here we show that in transfected cells
p14ARF also appears in Hsp70 positive extranucleolar inclusions. The formation of p14ARF
inclusions induces the parallel re-localization p53 and HDM2 to these sites that are also targeted
by PML bodies and proteasomes.
Conclusion: Our data show that co-localization between p53, HDM2 and p14ARF occurs at
extranucleolar sites. Accumulation of PML and proteasomes at these sites suggest that the
components of the nuclear inclusions are targeted for proteasome-mediated degradation.
Background
The INK4a locus on human chromosome 9p21 encodes
the p14ARF tumor suppressor protein, which uses an up-
stream promoter and a shifted frame in exon 2 (compared
to the p16 protein) [1,2]. The INK4a locus is often inacti-
vated by deletion or by methylation in human melano-
mas, lymphomas, and other tumors [3,4].
p14ARF has the ability to suppress growth through multi-
ple p53-dependent or p53-independent pathways [5–7].
p14ARF protein binds to HDM2 and inhibits its E3 ubiq-
uitin ligase activity [8]. p53 is a binding partner and ubiq-
uitination target of HDM2 [9–11]. In cells that harbour
wild type p53, p14ARF can associate with p53 bound
HDM2 forming tri-molecular complexes [12,13].
In human tumor cell lines, p14ARF is localized mainly to
nucleoli [13,14]. The nucleolus is one of the most charac-
terized nuclear compartments [15,16]. Nucleoli are as-
sembled around clusters of repeated ribosomal genes,
which are transcribed by RNA polymerase I. The nucleoli
are the sites of ribosomal biogenesis. They are also sites
for the maturation and processing of small nucleolar RNA
[17]. Nucleoli play an important role in the replication of
different viruses [18].
It was suggested that p14ARF targets HDM2 protein to the
nucleoli, blocking the shuttling of HDM2 to the cyto-
plasm, and consequently enriching the nucleus with p53
protein [13,19,20]. However, the literature data shows
contradictory data about p14ARF-HDM2 localization re-
porting that p14ARF targets HDM2 to the nucleoli [20],
HDM2 re-localizes p14ARF to the nucleoplasm [13], or
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these two proteins are found in different compartments
[5].
In the present study, our goal is to verify the localization
of p14ARF protein and to compare it with the localization
of other regulatory proteins, such as p53, HDM2, Rb, p27,
Hsp70, and PML.
Results
p14ARF localizes in nucleoli and/or nuclear inclusions of 
transfected cells
We transfected p14ARF, cloned into three different vec-
tors: pBabe that did not contain any tag (pBabe-p14ARF),
and as a fusion with GFP at the N-terminus (GFP-
p14ARF) and with DSRed at the C-terminus (p14ARF-
DSRed) into MCF7, Saos-2 and NIH3T3 cells lines. The
three different constructs produced proteins with very
similar localization patterns in all the three cell lines. Pic-
tures that were taken on MCF7 cells are used to illustrate
the findings of this paper. We found that p14ARF protein
accumulated in the nucleoli and/or in extra-nucleolar nu-
cleoplasmic inclusions of variable sizes (Figure 1). These
p14ARF nuclear inclusions were negative for the nucleolar
marker B23 (Figure 2) and were not surrounded by peri-
nucleolar heterochromatin. It was difficult to distinguish
nucleoli from the extranucleolar inclusions using only
phase contrast microscope. The p14ARF nuclear inclu-
sions were visible on the phase contrast as dark bodies in
similar manner as nucleoli. We found however that stain-
ing of the perinucleolar heterochromatin with Hoechst
33258 was a reliable marker to routinely discriminate be-
tween nucleoli and extranucleolar inclusions.
Figure 1
Full-length p14ARF expressed from the retroviral vector pBABE (pBabe-p14ARF) is localized to the nucleoli (full arrowheads) 
and to extra-nucleolar inclusions of MCF7 cells (hollow arrowheads). DNA – staining is shown in blue.Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/18
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p14ARF nuclear inclusions are targets for PML bodies
After p14ARF transfection, we observed that PML bodies
were re-distributed to the p14ARF nuclear inclusions (Fig-
ure 3). PML and p14ARF proteins showed a high level of
co-localization. However, PML protein was not detected
in the nucleoli that contained p14ARF protein. Here we
demonstrated a striking difference in the properties of the
nucleolar p14ARF and p14ARF that formed extranucleolar
inclusions.
Figure 2
Double staining for B23 and pBabe-p14ARF shows that pBabe-p14ARF forms extranucleolar inclusions as well as localizes to 
nucleoli in MCF7 cells. Red – B23, green – p14ARF, blue – DNA staining.Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/18
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Figure 3
PML bodies are randomly scattered in nuclei where pBabe-p14ARF exclusively localized to nucleoli (top row) but gradually 
associate with the p14ARF positive extranucleolar inclusions in parallel with their expansion (2nd–5th raw) in MCF7 cells. 
p14ARF positive nuclear inclusions are denoted by hollow arrowheads and nucleoli by full arrowheads. Green – p14ARF, red – 
PML protein, blue – DNA-staining.Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/18
Page 5 of 9
(page number not for citation purposes)
p14ARF nuclear inclusions relocalize proteasomes
In order to investigate whether the p14ARF nuclear inclu-
sions could be targets of the degradation pathway, we
have stained the transfected cells for the 20S core subunit
of the proteasomes. The 20S subunits of the proteasomes
were localized mainly to the cytoplasm of MCF7 cells.
When p14ARF was expressed in cells, the 20S core subu-
nits of the proteasomes were targeted to the nucleus and
co-localized with p14ARF in the extra-nucleolar inclu-
sions (Figure 4). Remarkably, the proteasomes were not
associated with p14ARF when it was present in the
nucleoli.
p14ARF nuclear inclusions accumulate Hsp70 protein
One of the stress response proteins, Hsp70, is often redis-
tributed both to the nucleus and to the nucleolus during
periods of cell stress. Here we show that in those p14ARF
transfected cells where p14ARF accumulated in the extra-
nucleolar inclusions Hsp70 was targeted to the nucleus
and showed a high grade of co-localization with p14ARF
extranuclear inclusions (Figure 5). No Hsp70 accumula-
tion was observed when the transfected p14ARF gathered
in the nucleolus.
p53 and HDM2 accumulate in p14ARF nuclear inclusions
We stained the cells for both p53 and HDM2 because
these two proteins were shown to form a tri-molecular
complex with p14ARF protein. Both proteins were found
in the extra-nucleolar p14ARF inclusions. Neither protein
was detected in nucleoli, even if p14ARF was localized to
the nucleoli (Figures 6 and 7). Formation of the p14ARF
inclusions has no effect on the distribution of other nucle-
ar proteins such as pRb or p27 (data not shown). Trans-
fection of p14ARF into MCF7 cells that contain wild type
p53 and HDM2 but lack endogeneous p14ARF did not in-
duce increased expression of p53.
Discussion
p14ARF protein is considered to be mainly nucleolar pro-
tein that directly interacts with HDM2 and regulates the
expression of the tumor suppressor protein p53. p14ARF
also appears to have a p53/HDM2 independent tumor
suppressor function on its own [5]. The sub-cellular local-
ization of p14ARF/HDM2 complex is still controversial.
Experiments on cell hybrids suggested that p14ARF se-
questers HDM2 in the nucleolus [20]. On the other hand
it was also shown that overexpressed HDM2 protein could
re-locate p14ARF into the nucleoplasm in the presence of
wild-type p53.
We have detected the formation of nuclear inclusions by
p14ARF that was expressed from three different vectors,
24–72 hours after transfection. Overexpressed HDM2 was
not required for the formation of the inclusions. The nu-
clear inclusions were very similar in size, and in
appearance in phase contrast microscope, to the nucleoli.
The lack of B23 protein and the absence of surrounding
perinuclear heterochromatin clearly indicated that the in-
clusions were extranucleolar structures.
PML bodies regularly targeted the p14ARF inclusions, but
not the p14ARF containing nucleoli. PML bodies are inter-
feron inducible, multifunctional nuclear organelles that
are involved in a number of cellular processes such as an-
tiviral defence, MHC class I dependent antigen presenta-
tion and regulation of gene expression. PML bodies also
likely play a role in the regulation of the degradation of
nuclear proteins. For example mutant, misfolded influen-
za nucleoprotein accumulates in PML bodies in cells
where proteasome mediated degradation is inhibited sug-
gesting that PML bodies function as the nuclear analogues
of the cytoplasmic aggresomes [21]. Accumulation of mu-
tant polyQ-containing cellular proteins in polyglutamine
(polyQ) neurodegenerative diseases [22] leads to the relo-
calization of PML bodies to the polyQ inclusions [23].
We also observed that the p14ARF nuclear inclusions, but
not the p14ARF containing nucleoli, showed accumula-
tion of Hsp70 protein and were targeted by proteasomes.
Importantly HDM2 and p53 also accumulated in p14ARF
inclusions but when p14ARF was localized to the nucleo-
li, p53 or HDM2 co-localization was not detected.
Our data suggests that p14ARF, although it often accumu-
lates in the nucleolus, does not sequestrate HDM2 in the
nucleolus. The complexes localize to the nucleoplasm.
p14ARF/HDM2 complexes also contain p53 and are tar-
Figure 4
20S proteasomes are targeted to pBbae-p14ARF positive 
nuclear inclusions (hollow arrowheads) but not to the nucle-
oli (full arrowheads) in MCF7 cells. Green – p14ARF, red – 
20S proteasome subunits, blue – DNA-staining.Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/18
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geted for proteasome mediated degradation with the help
of PML bodies. Overexpression of p14ARF leads to the
complete entrapment of HDM2 and p53 intro extranucle-
olar inclusion bodies.
Conclusions
Our data show that co-localization between p53, HDM2
and p14ARF occurs at extranucleolar sites. Accumulation
of PML bodies and proteasomes at these sites suggest that
the components of the nuclear inclusions are targeted for
proteasome-mediated degradation.
Methods
Plasmids
The following plasmids were used: full-length p14ARF
cDNA (encoding 132 residues), cloned in pBabe vector
(gift of Klas G. Wiman – CCK KI, Stockholm); and full-
length p14ARF fused to GFP in pEGFP-C1 and to DSRed
in pDsRed2 (both Clontech) in C-terminal and N-termi-
nal positions, respectively.
Cell cultures and transfections
In this study, MCF7, a breast cancer cell line, Saos-2, an os-
teosarcoma cell line, and NIH3T3, a mouse immortalized
fibroblasts were used. MCF7 cells expressed wild-type p53
at low levels, HDM2 at moderate levels and had a deleted
p14ARF gene. Saos-2 cells had a homozygous deletion at
the p53 loci and expressed moderate level of p14ARF.
Cells were cultured in Iscove's medium as described else-
where [24]. The culture was mycoplasma free as shown by
Hoechst DNA-staining. Transfections were performed us-
ing the LipofectAMINE PLUS Reagent and FuGene (Life
Technologies) according to the manufacturer's protocol.
The cells were grown and transfected on cover slips.
Antibodies
The following primary antibodies were used:
Mouse monoclonal antibody (mAb) against B-23/nucleo-
phosmin (NPM), a kind gift of P. K. Chan (Baylor College
of Medicine, Houston),
Figure 5
HDM2 protein (red) is re-distributed to pBabe-p14ARF (green) nuclear inclusions, but not to nucleoli that contain p14ARF in 
MCF7 cells. DNA staining is shown in blue.Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/18
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mAb against HDM2 Ab-1, Clone SMP14 (DAKO),
mAb against heat shock protein 70 (HSP70) (W27) (Santa
Cruz Biotechnology),
mAB against PML protein (PG-M3) (Santa Cruz
Biotechnology),
mAB against 20S proteasome (clone HP810) (Affiniti Re-
search Product Ltd),
mAb against p14ARF, 240 (supernatant), a kind gift of J.
Bartek (Danish Cancer Society),
mAb against p53 DO7 (BD PharMingen),
rabbit polyclonal anti-p14ARF, a kind gift of K. Wiman
(CCK, KI, Stockholm).
The following secondary antibodies were used:
horse anti-mouse Ig Texas Red conjugated (Vector Lab),
rabbit anti-mouse Ig FITC (DAKO),
swine anti-rabbit FITC (DAKO),
swine anti-rabbit TRITC (DAKO).
Normal mouse, swine, and rabbit sera were obtained
from DAKO.
Bisbenzimide (Hoechst 33258 from SIGMA) was added at
a concentration of 0.4 µg/mL to the secondary antibody
for DNA staining when needed.
Figure 6
p53 protein (red) co-localizes with pBabe-p14ARF (green) in the extra-nucleolar inclusions in MCF7 cells. DNA staining is 
shown in blue.Molecular Cancer 2003, 2 http://www.molecular-cancer.com/content/2/1/18
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Immunostainings
Cells were stained on coverslips after fixation in a mixture
of methanol and acetone (1:1) at -20°C. The immunos-
taining protocol has been described previously [24].
Microscopy, photo and image analyses
Images were captured using a DAS microscope Leitz DM
RB with a Hamamatsu dual-mode cooled charge-coupled
device (CCD) camera C4880. The 3D immunofluores-
cence images were generated from the reconstitution of a
series of de-blurred optical sections. Briefly, the images
were captured using a PXL cooled CCD camera (Photome-
trix) on a Zeiss Axiophot microscope equipped with Z-axis
motor, external shutter and excitation filter-wheel, con-
trolled by a MAC2000 LEP module. The computer pro-
gram, ST-RFH-bin2, that controlled the image acquisition
hardware and produced the digital images was developed
by us (Szekely, unpublished). The program captured three
times 13–17 images from three excitation series (Rhod-
amine-FITC-Hoechst) with focal planes 0.3 µm apart. The
incoming images were automatically corrected for dark
current noise and optical shining through, and de-blurred
using a nearest neighbour de-convolution algorithm. The
resultant image stacks were projected using the maximum
intensity projection algorithm producing a single-direc-
tion and stereo-pair projected images as described [25].
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